Edition:
India

Evonik Industries AG (EVKn.DE)

EVKn.DE on Xetra

24.03EUR
8:59pm IST
Change (% chg)

€-0.37 (-1.52%)
Prev Close
€24.40
Open
€24.37
Day's High
€24.37
Day's Low
€23.95
Volume
494,998
Avg. Vol
745,467
52-wk High
€32.77
52-wk Low
€21.03

Latest Key Developments (Source: Significant Developments)

Evonik Industries Expands Capacity For Specialty Alcohol ITDA
Wednesday, 11 Sep 2019 

Sept 11 (Reuters) - Evonik Industries AG ::EXPANDS CAPACITY FOR SPECIALTY ALCOHOL ITDA.  Full Article

Evonik Buys Surface Modification Tech Platform From Interface Biologics
Tuesday, 3 Sep 2019 

Sept 3 (Reuters) - Evonik Industries AG ::ACQUIRES A SURFACE MODIFICATION TECHNOLOGY PLATFORM FROM INTERFACE BIOLOGICS.  Full Article

Evonik To Defend FTC Lawsuit Seeking To Block Acquisition Of PeroxyChem
Saturday, 3 Aug 2019 

Aug 2 (Reuters) - Evonik Industries AG ::EVONIK ACQUISITION OF PEROXYCHEM DELAYED BY FTC LAWSUIT.EVONIK TO DEFEND FTC LAWSUIT SEEKING TO BLOCK ACQUISITION OF PEROXYCHEM.EVONIK INDUSTRIES- CONTINUES TO BELIEVE THAT DEAL WILL BENEFIT CUSTOMERS THROUGH COMBINATION OF EVONIK'S AND PEROXYCHEM'S COMPLEMENTARY BUSINESSES.  Full Article

Linde Starts Up New Plant To Supply Evonik Complex In Singapore
Thursday, 1 Aug 2019 

Aug 1 (Reuters) - LINDE PLC ::STARTS UP NEW PLANT TO SUPPLY EVONIK COMPLEX IN SINGAPORE.NEW PLANT COMPLEMENTS EXISTING FACILITY WHICH HAS BEEN SUPPLYING GASES TO EVONIK'S FIRST METHIONINE COMPLEX IN SINGAPORE SINCE 2014.  Full Article

Evonik Closes Sale Of Methacrylates Business To Advent Intl
Thursday, 1 Aug 2019 

Aug 1 (Reuters) - Evonik Industries AG ::CO. CLOSES SALE OF METHACRYLATES BUSINESS.METHACRYLATES BUSINESS TO TRANSFER TO ADVENT INTERNATIONAL EFFECTIVE JULY 31.DEDUCTIONS MAINLY DUE TO TRANSFER OF PENSION OBLIGATIONS OF 600 MILLION EUR TO BUYER AND FROM TAXES OF 200 MILLION EUR.ONE-OFF TAX OBLIGATIONS AMOUNT TO 260 MILLION EUR.  Full Article

Evonik Reports Q2 Net Income Of 228 Mln Eur
Thursday, 1 Aug 2019 

Aug 1 (Reuters) - Evonik Industries AG ::CONFIRMS FY OUTLOOK: SALES, ADJUSTED EBITDA TO REMAIN AT LEAST STABLE.SEES CONTINUED SOLID DEVELOPMENT IN H2.REPORTS Q2 SALES OF 3.306 BILLION EUR.REPORTS Q2 ADJUSTED EBITDA OF 566 MILLION EUR.REPORTS Q2 ADJUSTED EBIT OF 340 MILLION EUR.REPORTS Q2 NET INCOME OF 228 MILLION EUR.REFINITIV POLL FOR Q2 EVONIK SALES WAS 3.52 BILLION EUR, FOR NET PROFIT 223 MILLION EUR.  Full Article

RAG Stiftung Committed To Evonik Stake -Statement
Thursday, 6 Jun 2019 

June 6 (Reuters) - RAG Stiftung::EVONIK WILL REMAIN IMPORTANT PART OF OUR PORTFOLIO.WILL RETAIN SIGNIFICANT STAKE IN EVONIK.WE FULLY BACK STRATEGY OF EVONIK'S MANAGEMENT.WE EXPECT SUSTAINABLE AND PROFITABLE GROWTH OF EVONIK COMBINED WITH ATTRACTIVE DIVIDENDS.  Full Article

RAG Stiftung Committed To Evonik Stake -Evonik Chairman
Tuesday, 28 May 2019 

May 28 (Reuters) - Evonik Industries AG chairman::MAJOR SHAREHOLDER RAG STIFTUNG SAID IT DOESN'T INTEND TO REDUCE STAKE IMMEDIATELY AND WILL KEEP SIGNIFICANT STAKE OVER LONG TERM.  Full Article

Evonik To Hike Prices For Glycine Product Range
Tuesday, 28 May 2019 

May 28 (Reuters) - Evonik Industries AG ::WILL IMPLEMENT A PRICE INCREASE FOR GLYCINE PRODUCT RANGE.PRICE INCREASE OF 12% WILL BE IMPLEMENTED ON A GLOBAL LEVEL.INCREASE OF 12% WILL BE IMPLEMENTED ON A GLOBAL LEVEL.INCREASE FOR GLYCINE EFFECTIVE JULY 1(ST), 2019.IN RESPONSE TO RAPIDLY-ESCALATING COSTS FOR RAW MATERIALS OVER PAST MONTHS, THIS PRICE INCREASE BECAME NECESSARY.  Full Article

Evonik Industries AG - Evonik To Support Chinese Anti-Dumping Investigations For Methionine
Wednesday, 10 Apr 2019 

April 10 (Reuters) - Evonik Industries AG ::EVONIK TO SUPPORT CHINESE ANTI-DUMPING INVESTIGATIONS FOR METHIONINE.SAYS INVESTIGATION IS SAID TO BE COMPLETED BY APRIL 10, 2020.SAYS PERIOD UNDER CONSIDERATION FOR POSSIBLE DUMPING IS FOR THE CALENDAR YEAR 2018.  Full Article

Photo

U.S. sues to stop merger of hydrogen peroxide makers Evonik and PeroxyChem

WASHINGTON The U.S. Federal Trade Commission said on Friday it was suing to stop Evonik Industries AG's proposed purchase of rival hydrogen peroxide maker PeroxyChem Holding Company, citing concerns that the deal would lead to higher prices.